The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Cancer statistics in China, 2015
Open accessAbstract
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyroid carcinomas are more prevalent among women.”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [4]
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Self-citationGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citation中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Flagged first, then by citations
2 of the 85 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012
- Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42
- Chen Z, 2008, National Death Survey Report 2004–2005
- 2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122
- Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131
Cited by
Sorted by citations
Items 801–900 of 1,032
Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005–2013
Zhang, L., Li, J., Cong, X., Hu, X., Li, D., Wu, L., Hua, H., Yu, G., & Kerr, A. R. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.10.014 · Cited by 88
Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
Wang, D., Zheng, X., Fu, B., Nian, Z., Qian, Y., Sun, R., Tian, Z., & Wei, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.058 · Cited by 88
Zhao, G., Li, H., Yang, Z., Wang, Z., Xu, M.-Q., Xiong, S., Li, S., Wu, X., Liu, X., Wang, Z., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2475 · Cited by 88
Lin, Q., Qu, M., Zhou, B., Patra, H. K., Sun, Z., Luo, Q., Yang, W., Wu, Y., Zhang, Y., Li, L., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.037 · Cited by 88
Development and validation of prognostic nomogram for young patients with gastric cancer
Yu, C., & Zhang, Y. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.77 · Cited by 88
CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer
Yu, S., Zhang, Y., Li, Q., Zhang, Z., Zhao, G., & Xu, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2168-y · Cited by 88
Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer
Xu, L., Zhang, G., Shi, B., Liu, Y., Zou, T., Yan, W., Xiao, Y. P., Xue, H., Feng, F., Lei, J., et al. (2019) · Cancer Imaging · doi:10.1186/s40644-019-0274-9 · Cited by 88
Xu, P., Xiao, H., Yang, Q., Hu, R., Lianyong, J., Bi, R., Jiang, X., Wang, L., Mei, J., Ding, F., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0356-6 · Cited by 87
Chen, L., Kong, X., Wang, Z., Wang, X., Fang, Y., & Wang, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14934 · Cited by 88
Hua, X., Long, Z., Huang, X., Deng, J., He, Z., Guo, L., Zhang, W., & Lin, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01562 · Cited by 88
Jiao, S., Li, G., Zhang, D., Xu, Y., Liu, J., & Li, G. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.05.008 · Cited by 88
Peng, Y., Xiao, L., Rong, H., Ou, Z., Cai, T., Liu, N., Li, B., Zhang, L., Wu, F., Lan, T., et al. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105348 · Cited by 92
C hina national lung cancer screening guideline with low‐dose computed tomography (2015 version)
Zhou, Q., Fan, Y., Bu, H., Wang, Y., Wu, N., Huang, Y., Wang, G., Wang, X., & Qiao, Y. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12287 · Cited by 87
Mechanism of immune evasion in breast cancer
Wang, M., Zhang, C., Song, Y., Wang, Z., Wang, Y., Fang, L., Xu, Y.-J., Zhao, Y., Wu, Z., & Xu, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s126424 · Cited by 95
Xiong, W., Xu, Q.-P., Xu, L., Xiao, R., Cai, L., & He, F. (2017) · Oncotarget · doi:10.18632/oncotarget.21682 · Cited by 87
Li, J., Weng, Z., Xu, H., Zhang, Z., Miao, H., Chen, W., Liu, Z., Zhang, X., Wang, M., Xu, X., et al. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.11.001 · Cited by 88
Self-citationMiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4
Xu, X., Gao, F., Wang, J., Tao, L., Ye, J., Li, D., Ji, W., & Chen, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1423925 · Cited by 89
Chen, D., Sun, D., Wang, Z., Qin, W., Chen, L., Zhou, L., & Zhang, Y. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.06.041 · Cited by 87
Liang, R., Xiao, G., Wang, M., Li, X., Li, Y., Hui, Z., Sun, X., Qin, S., Zhang, B., Du, N., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.099 · Cited by 87
Guan, Q., Li, Y., Li, W., & Dong, Y. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201801221 · Cited by 89
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jiang, J., Chen, X., Ren, Z., & Zheng, S. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.11.002 · Cited by 100
Jiang, K., Liu, H., Xie, D., & Xiao, Q. (2019) · Oncology Letters · doi:10.3892/ol.2019.9952 · Cited by 87
Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment
Zhang, L., Du, S., Wang, X., Jiao, Y., Yin, L., Zhang, Y., & Guan, Y. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.03.216 · Cited by 87
Ma, F., Guan, Y., Yi, Z., Chang, L., Li, Q., Chen, S., Zhu, W., Guan, X., Li, C., Qian, H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32536 · Cited by 88
Lu, W., Zhong, L., Dong, D., Fang, M., Dai, Q., Leng, S., Zhang, L., Sun, W., Tian, J., Zheng, J., et al. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.07.018 · Cited by 87
[China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version)].
Zhou, Q., Fan, Y., Wang, Y., Qiao, Y., Wang, G., Huang, Y., Wang, X., Wu, N., Zhang, G., Zheng, X., et al. (2018) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2018.02.01 · Cited by 86
Spatial association between outdoor air pollution and lung cancer incidence in China
Xing, D., Xu, C., Liao, X., Xing, T., Cheng, S. P., Hu, M. G., & Wang, J. X. (2019) · BMC Public Health · doi:10.1186/s12889-019-7740-y · Cited by 88
Dai, Q., Zhang, T., Pan, J., & Li, C. (2020) · Journal of Cancer · doi:10.7150/jca.43446 · Cited by 87
Ouyang, L., Yan, B., Liu, Y., Mao, C., Wang, M., Liu, N., Wang, Z., Liu, S., Shi, Y., Chen, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0181-3 · Cited by 87
Liu, B., Yu, H., Zeng, X., Zhang, D., Gong, J., Tian, L., Qian, J., Zhao, L., Zhang, S., & Liu, R. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.129896 · Cited by 88
Self-citationYin, L., Cheng, N., Chen, P., Zhang, M.-Y., Li, N., Lin, X., He, X.-M., Wang, Y.-J., Xu, H.-X., Guo, W., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.632546 · Cited by 71
Zhuang, Z., Zhang, Y., Wei, M., Yang, X., & Wang, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.709070 · Cited by 87
Tang, B., Xu, W., Wang, Y., Zhu, J., Wang, H., Tu, J., Weng, Q., Kong, C., Yang, Y., Qiu, R., et al. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108872 · Cited by 87
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Zhang, W., Zhang, B., & Chen, X. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0848-3 · Cited by 89
Guo, X., Lv, X., Lv, X., Ma, Y., Chen, L., & Chen, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17211 · Cited by 87
Lu, C., Wang, H., Chen, S., Yang, R., Li, H., & Zhang, G. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13556 · Cited by 87
Female breast cancer incidence and mortality in C hina, 2013
Zuo, T., Zheng, R., Zeng, H., Zhang, S., & Chen, W. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12426 · Cited by 85
Self-citationLiu, T., Ge, X., Yu, J., Guo, Y., Wang, Y., Wang, W., & Cui, L. (2018) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-018-1796-5 · Cited by 86
Yan, W., Xu, H., Dai, J., Peng, J., Wang, W., Xia, L., & Zhou, F. (2018) · BioMed Research International · doi:10.1155/2018/1804086 · Cited by 87
Cai, X., Zhao, Z., Dong, J., Lv, Q., Yun, B., Liu, J., Shen, Y., Kang, J., & Li, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1439-y · Cited by 86
Hu, C., Zhou, H., Liu, Y., Huang, J., Liu, W., Zhang, Q., Tang, Q., Sheng, F., Li, G., & Zhang, R. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4864 · Cited by 83
Expression and function of FRA1 protein in tumors
Jiang, X., Xie, H., Dou, Y., Yuan, J., Zeng, D. X., & Xiao, S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05123-9 · Cited by 86
Expression profile of Toll‑like receptors in human breast cancer
Shi, S., Xu, C., Fang, X., Zhang, Y., Li, H., Wen, W., & Yang, G. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10853 · Cited by 86
Applications of hyperspectral imaging in the detection and diagnosis of solid tumors
Zhang, Y., Wu, X., He, L., Meng, C., Du, S., Bao, J., & Zheng, Y. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.53 · Cited by 86
Li, M., Xi, N., Wang, Y., & Liu, L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0494-3 · Cited by 91
Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
Jiang, D., Zhang, L.-J., Liu, W., Ding, Y., Yin, J., Ren, R., Li, Q., Chen, Y., Shen, J., Tan, X., et al. (2021) · 癌症：英文版 · doi:10.1002/cac2.12195 · Cited by 86
Radiomics and Deep Learning in Nasopharyngeal Carcinoma: A Review
Wang, Z., Fang, M., Zhang, J., Tang, L., Zhong, L., Li, H., Cao, R., Zhao, X., Liu, S., Zhang, R., et al. (2023) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2023.3269776 · Cited by 89
Chen, C.-L., Wang, Y., Huang, C.-Y., Zhou, Z.-Q., Zhao, J.-J., Zhang, X.-F., Pan, Q., Wu, J.-X., Weng, D., Tang, Y., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1373234 · Cited by 86
He, J., Zhou, M., Chen, X., Yue, D., Yang, L., Qin, G., Zhang, Z., Gao, Q., Wang, D., Zhang, C., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0378-z · Cited by 85
Self-citationDownregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer
Zhang, Y., Zhang, P., Wan, X., Su, X., Kong, Z., Zhai, Q., Xiang, X., Li, L., & Li, Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.013 · Cited by 85
Ma, M., Chen, S., Liu, Z., Xie, H., Deng, H., Shang, S., Wang, X., Xia, M., & Zuo, C. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s143315 · Cited by 85
Wang, J., Wang, S., Zhou, J., & Qian, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.018 · Cited by 85
Lu, Z., Li, Y., Che, Y., Huang, J., Sun, S., Mao, S., Lei, Y., Li, N., Sun, N., & He, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.013 · Cited by 86
Self-citationTang, H., Zhu, J., Du, W., Liu, S., Zeng, Y., Ding, Z., Zhang, Y., Wang, X., Liu, Z., & Huang, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0811-6 · Cited by 83
First Human Trial of High-Frequency Irreversible Electroporation Therapy for Prostate Cancer
Dong, S., Wang, H., Zhao, Y., Sun, Y., & Yao, C. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818789692 · Cited by 85
ZFAS1: a novel tumor-related long non-coding RNA
Dong, D. F., Mu, Z., Zhao, C., & Sun, M. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0623-y · Cited by 84
Li, X., Deng, Y., Tang, W., Sun, Q., Chen, Y., Chen, Y., Yan, B., Wang, Y., Wang, J., Wang, S., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00579 · Cited by 87
Wang, X., Wu, X., Zhang, Z., Ma, C., Wu, T., Tang, S., Zeng, Z., Huang, S., Gong, C., Yuan, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36214-5 · Cited by 85
Zhao, Z., Zou, S., Guan, X., Wang, M., Jiang, Z., Liu, Z., Li, C., Lin, H., Liu, X., Yang, R., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00650 · Cited by 85
Colorectal Cancer: An Overview
Duan, B., Zhao, Y., Bai, J. Y., Wang, J., Duan, X., Luo, X., Zhang, R., Pu, Y., Kou, M., Lei, J., et al. (2022) · Exon Publications eBooks · doi:10.36255/exon-publications-gastrointestinal-cancers-colorectal-cancer · Cited by 85
Yang, L., Peng, X., Jin, H., & Liu, J. (2019) · Gene · doi:10.1016/j.gene.2019.02.036 · Cited by 86
Zhang, Y., Han, Y. K., Gan, Q., Xiang, J., Jin, R., Chen, K., Che, J., Hang, J., & Li, H. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07273-3 · Cited by 85
Tian, F., Wang, J., Ouyang, T., Lü, N., Lu, J., Shen, Y., Bai, Y., Xie, X., & Ge, Q. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00688 · Cited by 85
Zhu, B., Liu, Y., Zuo, T., Cui, X., Li, M., Zhang, J., Yu, H., & Piao, H. (2019) · Cancer Medicine · doi:10.1002/cam4.2017 · Cited by 86
STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma
Lai, Y., Zhang, Z., Li, J., Li, W., Huang, Z., Zhang, C., Li, X., & Zhao, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.032 · Cited by 84
Bai, X., Shao, J., Zhou, S., Zhao, Z., Li, F., Xiang, R., Zhao, A. Z., & Pan, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1478-3 · Cited by 85
Liu, J.-Y., Peng, C., Yang, X., Huang, C., & Li, Y. (2018) · PubMed Central · Cited by 85
Li, J., Wang, Y., Wang, X., & Yang, Q. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-01817-8 · Cited by 85
Circulating exosomal small RNAs are promising non‐invasive diagnostic biomarkers for gastric cancer
Ge, L., Zhang, N., Li, D., Wu, Y., Wang, H., & Wang, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16077 · Cited by 84
Xu, J.-C., Chen, T., Liao, L.-T., Chen, T., Li, Q., Xu, J., Hu, J., Zhou, P., & Zhang, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53795 · Cited by 85
LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells
Yue, Z., Yuan, Z., Zeng, L., Wang, Y., Lai, L., Li, J., Sun, P., Xue, X., Qi, J., Yang, Z., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700897r · Cited by 82
Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells
Liu, G., Fan, X., Tang, M., Chen, R., Wang, H., Jia, R., Zhou, X., Jing, W., Wang, H., Yang, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.033 · Cited by 84
Yang, R., Liu, M.-H., Liang, H.-W., Guo, S., Guo, X., Yuan, M., Lian, H.-B., Yan, X., Zhang, S.-W., Chen, X., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0569-4 · Cited by 89
Self-citationWu, Y., Zhang, X., Li, Z., Yan, H.-B., Qin, J., & Li, T. (2017) · Food & Function · doi:10.1039/c6fo01535b · Cited by 84
Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges
Jiang, J., Lao, Y.-C., Yuan, B., Yin, J., Liu, X., Chen, L., & Zhong, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15411 · Cited by 84
Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer
Zhu, M., Yan, C., Ren, C., Huang, X., Zhu, X., Gu, H., Wang, M., Wang, S., Gao, Y., Ji, Y. I., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.017 · Cited by 86
Cai, Z., Chen, G., Zeng, Y., Dong, X., Lin, M., HUANG, X.-H., Zhang, D., Liu, X., & Liu, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30798 · Cited by 84
Liu, L., Liu, J., Шао, Д., Deng, Q., Tang, H., Zu, L., Chen, X., Guo, F., Lin, Y., Mao, M., et al. (2017) · Cancer Science · doi:10.1111/cas.13410 · Cited by 87
Self-citationLong, F., He, Y., Fu, H., Li, Y., Bao, X., Wang, Q., Wang, Y., Xie, C., & Lou, L. (2019) · Cancer Science · doi:10.1111/cas.13957 · Cited by 84
Wu, M., Li, J., An, Y., Li, P., Xiong, W., Li, J., Yan, D., Wang, M., & Zhong, G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02101 · Cited by 84
Song, X., Du, R., Gui, H., Zhou, M., Zhong, W., Mao, C., & Ma, J. (2019) · Oncology Reports · doi:10.3892/or.2019.7400 · Cited by 84
Sun, X., Feng, Q.-X., Xu, X., Zhang, J., Zhu, F., Yang, Y.-H., & Zhang, Y. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.19.21617 · Cited by 84
Dai, Q., Zhang, T., & Li, C. (2020) · Cancer Management and Research · doi:10.2147/cmar.s243796 · Cited by 84
Wang, K., Liu, X., Liu, Q., Ho, I. H. T., Wei, X., Yin, T., Zhan, Y., Zhang, W., Zhang, W., Chen, B., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02880-5 · Cited by 88
Zhang, T., Chen, H., Yin, X., He, Q., Man, J., Yang, X., & Lü, M. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.01.02 · Cited by 84
Guo, W., Tan, F., Huai, Q., Wang, Z., Shao, F., Zhang, G., Yang, Z., Li, R., Xue, Q., Gao, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669750 · Cited by 84
Self-citationLi, K., Yao, T., Zhang, Y., Li, W., & Wang, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62728 · Cited by 84
Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2‐mediated autophagy
Fang, L., Lv, J., Xuan, Z., Li, B., Li, Z., He, Z., Li, F., Xu, J., Wang, S., Xia, Y., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.708 · Cited by 85
Expression profile of circular RNAs in human gastric cancer tissues
Huang, Y., Jie, N., Zou, K., & Weng, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6916 · Cited by 84
Anti-tumor effects of the American cockroach, Periplaneta americana
Zhao, Y., Yang, A., Tu, P., & Hu, Z. (2017) · Chinese Medicine · doi:10.1186/s13020-017-0149-6 · Cited by 84
Zhao, A., Qian, Y., Sun, H., Hou, X., Pan, J., Liu, X., Zhou, W. J., Chen, Y.-Z., Jiang, X., Li, Z., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.05.003 · Cited by 84
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer
Li, J., He, Y., Tan, Z., Lu, J., Li, L., Song, X., Shi, F., Xie, L., You, S., Luo, X., et al. (2018) · Theranostics · doi:10.7150/thno.21524 · Cited by 85
Liu, J., Dai, Y., Zhou, F., Long, Z., Li, Y., Liu, B., Xie, D., Tang, J. H., Tan, J., Yao, K., et al. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.05.024 · Cited by 83
Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy
Dong, X., Wang, Y., Zhou, Y., Wen, J., Wang, S., & Shen, L. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.87 · Cited by 83
Aptamer-Based Dual-Functional Probe for Rapid and Specific Counting and Imaging of MCF-7 Cells
Yang, B., Chen, B., He, M., Yin, X., Xu, C., & Hu, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04927 · Cited by 83
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Chen, S., Pu, J., Bai, J., Yin, Y., Wu, K., Wang, J., Shuai, X., Gao, J., Tao, K., Wang, G., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0670-6 · Cited by 83
Chen, Y., Mathy, N. W., & Lu, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8922 · Cited by 83
Lung Cancer Screening with Low-Dose CT: Baseline Screening Results in Shanghai
Fan, L., Wang, Y., Zhou, Y., Li, Q., Yang, W., Wang, S., Shan, F., Zhang, X., Shi, J., Chen, W., et al. (2018) · Academic Radiology · doi:10.1016/j.acra.2018.12.002 · Cited by 84
Self-citationWu, S., Sun, H., Wang, Y., Yang, X., Meng, Q., Yang, H., Zhu, H., Tang, W., Li, X., Aschner, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0773 · Cited by 83
Ding, X., Cheng, J., Pang, Q., Wei, X., Zhang, X., Wang, P., Yuan, Z., & Qian, D. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.08.009 · Cited by 84
Metadata
- Authors
- Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
- Affiliations
- Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Cancer Council Queensland (AU)
- Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Centre international de recherche sur le cancer (FR)
- American Cancer Society (US)
- The University of Sydney (AU)
- Director National Cancer Center Beijing China.
- Corresponding author
- Chen, Wanqing
- ORCID
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2016-01-25
- Volume
- 66
- Issue
- 2
- Pages
- 115-132
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2272984102
- Cited by
- 17,038
- References
- 85
- Citations by year
- 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486
- FWCI
- 1269.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- CA A Cancer Journal for Clinicians (publishedVersion)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion, other-oa)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- National Health and Family Planning Commission of China
- Ministry of Science and Technology (2014FY121100)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Keywords
- cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
- MeSH terms
- Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
